organization · Reporting owner
PALVELLA THERAPEUTICS, INC.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PALVELLA THERAPEUTICS, INC.PVLA · Entity 4452 | Chief Scientific Officer | February 05, 2025 | February 07, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PALVELLA THERAPEUTICS, INC.
Report date February 05, 2025 · Filed February 07, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Incentive Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.76 · Expires 2035-02-05 | Direct | 5,373 |
Reported balance
After 2025-02-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-02-05 · Grant · Acquired 5,373 · Balance 5,373 F1: The stock options will vest in equal monthly tranches over 48 months |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.76 · Expires 2035-02-05 | Direct | 123,559 |
Reported balance
After 2025-02-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-02-05 · Grant · Acquired 123,559 · Balance 123,559 F1: The stock options will vest in equal monthly tranches over 48 months |
Filing footnotes · ownership attribution and instrument terms
F1: The stock options will vest in equal monthly tranches over 48 months
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 05, 2025 Filed Feb 7, 2025 21:30 UTC | PALVELLA THERAPEUTICS, INC. PVLA · Entity 4452 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 123,559 | $0.00 Strike: $14.76 | $0.00 |
DisclosureSEC source: 0001583648-25-000015 · edgardoc.xml · derivative · entry 2 PALVELLA THERAPEUTICS, INC. · CIK 0001583648 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,559 Underlying: Common Stock · 123,559 shares Expires 2035-02-05 F1 · derivative.exercise_date: The stock options will vest in equal monthly tranches over 48 months Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 21:30 UTC | PALVELLA THERAPEUTICS, INC. PVLA · Entity 4452 | GrantIncentive Stock Option (right to buy) · Derivative | 5,373 | $0.00 Strike: $14.76 | $0.00 |
DisclosureSEC source: 0001583648-25-000015 · edgardoc.xml · derivative · entry 1 PALVELLA THERAPEUTICS, INC. · CIK 0001583648 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,373 Underlying: Common Stock · 5,373 shares Expires 2035-02-05 F1 · derivative.exercise_date: The stock options will vest in equal monthly tranches over 48 months Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 21:30 UTC | PALVELLA THERAPEUTICS, INC. PVLA · Entity 4452 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 123,559 | $0.00 Strike: $14.76 | $0.00 |
DisclosureSEC source: 0001583648-25-000014 · edgardoc.xml · derivative · entry 2 PALVELLA THERAPEUTICS, INC. · CIK 0001583648 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,559 Underlying: Common Stock · 123,559 shares Expires 2035-02-05 F1 · derivative.exercise_date: The stock options will vest in equal monthly tranches over 48 months Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 21:30 UTC | PALVELLA THERAPEUTICS, INC. PVLA · Entity 4452 | GrantIncentive Stock Option (right to buy) · Derivative | 5,373 | $0.00 Strike: $14.76 | $0.00 |
DisclosureSEC source: 0001583648-25-000014 · edgardoc.xml · derivative · entry 1 PALVELLA THERAPEUTICS, INC. · CIK 0001583648 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,373 Underlying: Common Stock · 5,373 shares Expires 2035-02-05 F1 · derivative.exercise_date: The stock options will vest in equal monthly tranches over 48 months Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 21:29 UTC | PALVELLA THERAPEUTICS, INC. PVLA · Entity 4452 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 123,559 | $0.00 Strike: $14.76 | $0.00 |
DisclosureSEC source: 0001583648-25-000012 · edgardoc.xml · derivative · entry 2 PALVELLA THERAPEUTICS, INC. · CIK 0001583648 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,559 Underlying: Common Stock · 123,559 shares Expires 2035-02-05 F1 · derivative.exercise_date: The stock options will vest in equal monthly tranches over 48 months Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 21:29 UTC | PALVELLA THERAPEUTICS, INC. PVLA · Entity 4452 | GrantIncentive Stock Option (right to buy) · Derivative | 5,373 | $0.00 Strike: $14.76 | $0.00 |
DisclosureSEC source: 0001583648-25-000012 · edgardoc.xml · derivative · entry 1 PALVELLA THERAPEUTICS, INC. · CIK 0001583648 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,373 Underlying: Common Stock · 5,373 shares Expires 2035-02-05 F1 · derivative.exercise_date: The stock options will vest in equal monthly tranches over 48 months Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 21:29 UTC | PALVELLA THERAPEUTICS, INC. PVLA · Entity 4452 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 243,831 | $0.00 Strike: $14.76 | $0.00 |
DisclosureSEC source: 0001583648-25-000013 · edgardoc.xml · derivative · entry 1 PALVELLA THERAPEUTICS, INC. · CIK 0001583648 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 243,831 Underlying: Common Stock · 243,831 shares Expires 2035-02-05 F1 · derivative.exercise_date: The stock options will vest in equal monthly tranches over 48 months Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.